One and Done? New Study Suggests that One Dose of HPV Vaccine May Be Enough
The results of large-scale study suggest that one shot of the HPV vaccine may be enough to protect young people from HPV and related issues like cervical cancer.
The results of large-scale study suggest that one shot of the HPV vaccine may be enough to protect young people from HPV and related issues like cervical cancer.
A new study comparing cancer screening rates from 2019 (pre-pandemic) to those in 2021 (mid-pandemic) and 2023 (post-pandemic) found that cervical cancer screening rates lagged behind.
HPV self-collection is a great new option for cervical cancer screening. It is easy to do, and lets you avoid a speculum exam which many people find uncomfortable.
The Cervical Cancer Survivor Series is an eight-part podcast series sharing stories from cervical cancer survivors across the country, touching on topics including diagnosis, treatment, and survivorship, as well as advice for others whose lives are impacted by this preventable disease.
The FDA recently approved HPV testing using self-collected samples. Experts hope allowing people to collect their own samples will increase screening rates.
A new study revealed a disturbing trend in health knowledge; fewer people seem to understand the connection between HPV and certain types of cancer including cervical, oral, anal, and penile cancers.
Is one shot enough? A recent study adds to evidence that one dose of the HPV vaccine might be enough to provide protection against cervical cancer.
An exciting new study in Scotland found no cases of invasive cervical cancer in young women who had gotten the HPV vaccine by the time they were 14.
Mailing cervical cancer screening kits directly to people’s home may be a good strategy for getting more people screened, a new study says.